TREM-1 and TREM-2 Expression on Blood Monocytes Could Help Predict Survival in High-Grade Glioma Patients

<div>Scatter plots showing correlations of HMGB1 with percentage of CD14<sup>+</sup> TREM-1<sup>+</sup> cells, CD14<sup>+</sup> TREM-2<sup>+</sup> cells, and TREM-1/TREM-2 ratio in all gliomas (HMGB1 values corrected by a <span class="nowrap"><svg height="9.01194pt" id="M60" style="vertical-align:-0.04981995pt" version="1.1" viewbox="-0.0498162 -8.96212 9.12937 9.01194" width="9.12937pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M669 636L663 650H260C230 650 221 652 208 675H186C177 621 162 548 144 481L173 479C195 534 211 560 226 578C248 604 266 615 373 615H544C460 511 114 112 23 16L31 0H561C577 34 611 135 622 170L594 182C566 125 544 88 515 65C481 38 416 35 319 35C249 35 197 37 152 41C270 184 542 501 669 636Z"></path></g></svg>-</span>score).</div>

Mediators of Inflammation

fig7

Figure 7

Figure 7: TREM-1 and TREM-2 Expression on Blood Monocytes Could Help Predict Survival in High-Grade Glioma Patients 